← Back to Disease Advocacy Hub
Lung Cancer
Below Median Funding/DALYCategory: Cancer
Lung cancer is the deadliest cancer in the U.S. by a wide margin. Despite causing 3.8% of all DALYs, it receives only ~$100 per DALY in NIH research funding, the lowest ratio of any cancer type.
DALYs / year
4,186,491
GBD 2019
Share of US Burden
3.8%
of all DALYs
NIH Funding
$419M
FY 2019
Funding per DALY
$100
Median: $218
Key Facts
- Kills more Americans than breast, colon, and prostate cancers combined
- Over 4.2 million DALYs lost annually
- Received $419 million in NIH funding in 2019 (~$100 per DALY)
- Lowest funding-to-burden ratio of any cancer studied (Ballreich et al.)
How Does This Compare?
COPD
$22
Stroke
$91
→ Lung Cancer
$100
Ischemic Heart Disease
$161
Depressive Disorders
$218
Diabetes
$246
Drug Use Disorders
$250
Chronic Kidney Disease
$284
Alzheimer's & Dementias
$1,183
Funding per DALY = NIH FY 2019 spending ÷ GBD 2019 DALYs. Lower = more underfunded relative to burden.
Sources
Advocate for Lung Cancer Research
Use our tool to find your representatives and send them a letter about increasing research funding for lung cancer.
Contact Your Representative